Aflac Incorporated AFL
Nov 6, 2026, 2:37 PM EST
- YTD
- +13.03%
- 1 year
- +9.62%
- Market cap
- 61.77B
- Revenue (ttm)
- 18.07B
- Profit margin
- 26.91%
- EPS (ttm)
- 6.85
- Shares out
- 501.34M
- P/E ratio
- 18.19
- Forward P/E
- 16.58
- Dividend
- 2.44 (1.97%)
- Ex-dividend date
- Aug 18, 2026
- YTD return
- +13.03%
- 1-year return
- +9.62%
- Volume
- 799.10K
- Avg volume
- 1.96M
- Open
- 123.64
- Previous close
- 126.24
- Day's range
- 123.61 – 125.77
- 52-week range
- 106.20 – 129.55
- Beta
- 0.55
- Price target
- 117.33 (-5.9%)
- Earnings date
- Feb 3, 2027
5D +0.32 (+0.26%)
Key statistics
- Enterprise value
- 70.06B
- PEG ratio
- 1.18
- Price / sales
- 3.50
- Price / book
- 2.22
- Dividend yield
- 1.95%
- Payout ratio
- 25.59%
- Revenue growth
- -1.00%
- Free cash flow
- 5.15B
- Total cash
- 8.94B
- Total debt
- 16.18B
- Return on equity
- 16.91%
- Short % of float
- 2.60%
- 50-day average
- 117.19
- 200-day average
- 116.10
Analyst view
- Target (low)
- 101.00
- Target (mean)
- 117.33
- Target (high)
- 138.00
- Strong buy2
- Buy1
- Hold8
- Sell3
- Strong sell1
Next earnings
Feb 3, 2027
Expected Feb 3, 2027. Consensus EPS estimate 1.73.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 3, 2027 | Dec 30, 2026 | 1.74 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 1.80 | 2.43 | +0.63 | +35.00% |
| Aug 6, 2026 | Jun 30, 2026 | 1.76 | 1.75 | -0.01 | -0.57% |
| Apr 29, 2026 | Mar 31, 2026 | 1.79 | 1.75 | -0.04 | -2.23% |
| Feb 4, 2026 | Dec 31, 2025 | 1.69 | 1.57 | -0.12 | -7.10% |
| Nov 4, 2025 | Sep 30, 2025 | 1.77 | 2.49 | +0.72 | +40.68% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2026 | JP Morgan | main | Neutral | Neutral |
| Oct 12, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Oct 9, 2026 | Keefe, Bruyette & Woods | main | Market Perform | Market Perform |
| Oct 7, 2026 | Mizuho | main | Underperform | Underperform |
| Oct 7, 2026 | Barclays | main | Underweight | Underweight |
| Oct 6, 2026 | UBS | main | Neutral | Neutral |
About Aflac Incorporated
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
- Sector
- Financial Services
- Industry
- Insurance - Life
- Country
- United States
- Website
- aflac.com
News
Aflac Q3 Earnings Call Highlights 
Aflac Q3 2026 Earnings Call Transcript 
Aflac (AFL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates 
Aflac (AFL) Surpasses Q3 Earnings and Revenue Estimates 
Aflac Q3 Adj. EPS $2.43 Beats $1.79 Estimate, Sales $3.271B Miss $4.122B Estimate 
Aflac Incorporated Announces Third Quarter 2026 Results, Declares Fourth Quarter Dividend 
ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test 
ALL, MET, AFL or PRI: Which Insurer Has the Edge for a Q3 Beat? 
For Aflac, 25 years of holiday giving is just ducky! 
Will Lower Investment Income Weigh on Aflac's Q3 Earnings?
Your note
Sign in to keep a note on AFL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AMOS DANIEL P | Chief Executive Officer | Stock Gift | Feb 19, 2026 | 2,540,880 |
| BOWERS WILLIAM PAUL | Director | Stock Award(Grant) | May 3, 2026 | 75,666 |
| BRODEN MAX | Chief Financial Officer | Stock Award(Grant) | Feb 9, 2026 | 0 |
| DYSLIN BRADLEY EUGENE | Officer | Stock Award(Grant) | Feb 9, 2026 | 44,677 |
| JAPAN POST HOLDINGS CO., LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 14, 2026 | 0 |
| KOIDE MASATOSHI | Officer | Sale | Mar 10, 2026 | 86,422 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Japan Post Holdings Co., Ltd. | 10.06% | 50,445,290 | 6.37B | Sep 29, 2026 |
| Blackrock Inc. | 6.96% | 34,915,032 | 4.41B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 5.96% | 29,902,916 | 3.78B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.86% | 24,356,406 | 3.08B | Jun 29, 2026 |
| State Street Corporation | 4.69% | 23,513,644 | 2.97B | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.11% | 10,600,232 | 1.34B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.90% | 14,541,743 | 1.84B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.37% | 11,868,459 | 1.50B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 1.98% | 9,926,238 | 1.25B | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.19% | 5,945,753 | 750.83M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.16% | 5,798,735 | 732.26M | Sep 29, 2026 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.10% | 5,520,654 | 697.15M | Sep 29, 2026 |